Patisiran
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 393 publications
Extracellular vesicle-based delivery systems for nucleic acid therapeutics.
Journal: Molecular therapy. Nucleic acids
Published: April 06, 2026
Efficacy of Suppression of Serum Transthyretin With Patisiran and Vutrisiran in Variant ATTR Amyloidosis: An Observational Crossover Study.
Journal: Circulation
Published: February 02, 2026
Impact of disease-modifying therapies on imaging parameters in cardiac amyloidosis: A systematic review and meta-analysis.
Journal: Current problems in cardiology
Published: January 07, 2026
Precision medicine with pioneering RNAi therapeutics in ATTR amyloidosis: from bench to bedside.
Journal: European journal of internal medicine
Published: December 20, 2025
Emerging nanotechnology-enabled siRNA oral delivery platforms.
Journal: Nanomedicine (London, England)
Published: December 06, 2025
Efficacy and Safety of Vutrisiran in Patients with Hereditary Transthyretin-mediated Amyloidosis with Polyneuropathy: Analysis of the East Asian Subpopulation from HELIOS-A.
Journal: Neurology and therapy
Published: December 05, 2025
Role SGLT2 inhibitor therapy in patients with transthyretin cardiac amyloidosis: a GRADE assessed systematic review and meta-analysis.
Journal: Acta cardiologica
Published: December 05, 2025
Comparative analysis of clinically approved lipid nanoparticles for intranasal siRNA delivery against SARS-CoV-2.
Journal: Drug delivery and translational research
Published: December 02, 2025
Dually Decorated Palmitate-Containing Lipid Nanoparticles for the Targeted Delivery of siRNAs against HER2 and Hsp27 in HER2+ Breast Cancer.
Journal: Journal of medicinal chemistry
Published: November 24, 2025
Class-Specific Adverse Events of Patients Treated with Small Interfering RNA Therapeutics: A Disproportionality Analysis of the United States Food and Drug Administration Adverse Event Reporting System Database Based on the MY FAERS Platform.
Journal: Nucleic acid therapeutics
Published: November 22, 2025
Lipid Nanoparticle Library Screen Reveals Lymphatic Endothelial Cell-Targeting Lipid Nanoparticle for Delivering Vascular Endothelial Growth Factor C mRNA after Lymphatic Injury.
Journal: ACS nano
Published: November 21, 2025
Last Updated: 04/28/2026